The Social Radars Founder Mode: Sajith Wickramasekara, Founder & CEO, Benchling
35 snips
Oct 17, 2025 Sajith Wickramasekara, Founder and CEO of Benchling, shares insights from his journey in life sciences software. He discusses Benchling's vital role in expediting drug development and its impact during the COVID era with rapid monoclonal antibody advancements. Sajith defines 'founder mode' as a deep sense of ownership and emphasizes the importance of leaders engaging with customers to preserve company culture. He reflects on the challenges of growth, the necessity of swift leadership corrections, and the value of embracing conflict for better decision-making.
AI Snips
Chapters
Transcript
Episode notes
Software Can Modernize Drug Discovery
- Benchling builds modern software to speed scientific progress in biotech and pharma.
- Life sciences still rely on paper and spreadsheets, so software can meaningfully improve drug development.
Benchling Used In COVID Antibody Work
- During COVID, companies using Benchling helped produce monoclonal antibodies before vaccines arrived.
- Benchling plus robotics and lab work enabled faster outcomes in that emergency context.
Founder Mode Is Relentless Ownership
- Founder mode equals an ownership mentality that cares about every detail across the company.
- Letting substandard work pass signals acceptance and lowers company standards.